These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6209428)

  • 1. Candicidin in treatment of benign prostatic hypertrophy.
    Madsen PO; Dørflinger T; Frimodt-Møller PC; Jensen KM
    J Urol; 1984 Dec; 132(6):1235-8. PubMed ID: 6209428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candicidin treatment of prostatism: a prospective double-blind placebo-controlled study.
    Jensen KM; Madsen PO
    Urol Res; 1983; 11(1):7-10. PubMed ID: 6190290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind trial of the effects of candicidin on patients with benign prostatic hypertrophy.
    Abrams PH
    Br J Urol; 1977 Feb; 49(1):67-71. PubMed ID: 65196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candicidin: physiologic effect on prostate.
    Sporer A; Cohen S; Kamat MH; Seebode JJ
    Urology; 1975 Sep; 6(3):298-304. PubMed ID: 51533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Candicidin treatment of benign hypertrophy of the prostate].
    Jensen SK; Hammen S
    Ugeskr Laeger; 1982 Jan; 144(1):26-7. PubMed ID: 6175063
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of raveron and levorin on urination recovery in prostatic adenoma and chronic prostatitis].
    Savin VF; Antonov NM; Arkannikov AB
    Urol Nefrol (Mosk); 1982; (2):22-4. PubMed ID: 6177084
    [No Abstract]   [Full Text] [Related]  

  • 7. The efficacy of bromocriptine in benign prostatic hypertrophy. A double-blind study.
    Van Poppel H; Boeckx G; Westelinck KJ; Vereecken RL; Baert L
    Br J Urol; 1987 Aug; 60(2):150-2. PubMed ID: 2444308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of candicidin in benign prostatic hypertrophy.
    Orkin LA
    Urology; 1974 Jul; 4(1):80-4. PubMed ID: 21322990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A double-blind trial on the effect of bunazosin hydrochloride for the symptoms of benign prostatic hypertrophy].
    Kumamoto Y; Tsukamoto T; Yachiku S; Kaneko S; Koyanagi T; Togashi M; Maru A; Tsuchida S; Nishizawa O; Orikasa S
    Hinyokika Kiyo; 1990 Oct; 36(10):1213-32. PubMed ID: 1702262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial.
    Porst H; Kim ED; Casabé AR; Mirone V; Secrest RJ; Xu L; Sundin DP; Viktrup L;
    Eur Urol; 2011 Nov; 60(5):1105-13. PubMed ID: 21871706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urodynamic and clinical effect of alpha-adrenergic blocker (phenoxybenzamine) in patients with benign prostatic hyperplasia.
    Chen KK; Chang LS; Chen MT; Huang JK; Yin JH; Lin SN; Lin AD
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Feb; 41(2):127-30. PubMed ID: 2458811
    [No Abstract]   [Full Text] [Related]  

  • 12. A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia.
    Elhilali MM; Ramsey EW; Barkin J; Casey RW; Boake RC; Beland G; Fradet Y; Trachtenberg J; Orovan WL; Schick E; Klotz LH
    Urology; 1996 Mar; 47(3):335-42. PubMed ID: 8633398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letter: Candicidin for benign prostatic hypertrophy.
    Tessler AN
    Urology; 1974 Oct; 4(4):494-5. PubMed ID: 4138275
    [No Abstract]   [Full Text] [Related]  

  • 14. A multicenter, double-blind, placebo-controlled trial of the efficacy of prazosin in the treatment of dysuria associated with benign prostatic hypertrophy.
    Le Duc A; Cariou G; Baron C; Cukier J; Quentel P; Faure G; Rambeaud JJ; Navratil H; Costa P; Richaud JJ
    Urol Int; 1990; 45 Suppl 1():56-62. PubMed ID: 1690483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A placebo-controlled double-blind study of the effect of phenoxybenzamine in benign prostatic obstruction.
    Caine M; Perlberg S; Meretyk S
    Br J Urol; 1978 Dec; 50(7):551-4. PubMed ID: 88984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of permixon in benign prostatic hypertrophy.
    Reece Smith H; Memon A; Smart CJ; Dewbury K
    Br J Urol; 1986 Feb; 58(1):36-40. PubMed ID: 2418902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of levorin on the chromatin of the prostate of dogs in its hypertrophy].
    Kravchenko LS; Oksman AIa; Konstantinova IM; Tereshin IM
    Antibiotiki; 1979 Mar; 24(3):212-7. PubMed ID: 87145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tadalafil once daily for lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a randomized placebo- and tamsulosin-controlled 12-week study in Asian men.
    Yokoyama O; Yoshida M; Kim SC; Wang CJ; Imaoka T; Morisaki Y; Viktrup L
    Int J Urol; 2013 Feb; 20(2):193-201. PubMed ID: 22958078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of megestrol acetate on uroflow rates in patients with benign prostatic hypertrophy: double-blind study.
    Geller J; Nelson CG; Albert JD; Pratt C
    Urology; 1979 Nov; 14(5):467-74. PubMed ID: 92091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe].
    Chapple ChR; Montorsi F; Tammela TL; Wirth M; Koldewijn E; Fernandez Fernandez E
    Urologiia; 2012; (5):38-42, 44-5. PubMed ID: 23342615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.